456160.KQ G2G Bio (지투지바이오) Loading...

Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
All directions✓
▲ Long✓
▼ Short✓
⛔ Avoid✓
✂ Close✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
? ?
03:00
Sep 15
Lee Kwon-hee CEO, Economist 815 Money Talk (815머니톡)
G2G Bio underowned with good news.
G2G Bio rose sharply with little investor attention despite positive news on monthly dementia injection safety and its microsphere/sustained-release technology.
456160.KQ 1ST
MED

About 456160.KQ Investor Commentary

Across the available history and selected sources, Buzzberg tracks 456160.KQ (G2G Bio (지투지바이오)) across 1 sources: 1 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 100% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 1 total trade idea tracked. Past 7 days, before deduplication: 1 bullish. Latest voices: Lee Kwon-hee.